Skip to main navigation Skip to search Skip to main content

Which Are the Best Tyrosine Kinase Inhibitors for Newly Diagnosed Chronic Myelogenous Leukemia?

Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

Period30 May 2025 → 3 Jun 2025
Event titleAmerican Society of Clinical Oncology (ASCO) Annual Meeting 2025
Event typeConference
LocationChicago, United StatesShow on map
Degree of RecognitionInternational

Keywords

  • Tyrosine
  • Kinase
  • Chronic Myelogenous Leukaemia